MedPath

Silver nitrate

Generic Name
Silver nitrate
Brand Names
Styptstix
Drug Type
Small Molecule
Chemical Formula
AgNO3
CAS Number
7761-88-8
Unique Ingredient Identifier
95IT3W8JZE

Overview

Silver nitrate is an inorganic compound with the chemical formula AgNO3. In its solid form, silver nitrate is coordinated in a trigonal planar arrangement. It is often used as a precursor to other silver-containing compounds. It is used in making photographic films, and in laboratory setting as a staining agent in protein visualization in PAGE gels and in scanning electron microscopy.

Background

Silver nitrate is an inorganic compound with the chemical formula AgNO3. In its solid form, silver nitrate is coordinated in a trigonal planar arrangement. It is often used as a precursor to other silver-containing compounds. It is used in making photographic films, and in laboratory setting as a staining agent in protein visualization in PAGE gels and in scanning electron microscopy.

Indication

1%~2%溶液用于新生儿淋菌性眼炎的预防;0.5%~1%溶液用于结膜炎、沙眼急性期;0.3%溶液制成敷料用于Ⅱ度和清创后的Ⅲ度大面积烧伤,以预防铜绿假单胞菌、变形杆菌和其他革兰阴性菌的感染;10%~20%溶液或硝酸银棒局部使用,用于腐蚀生长过剩肉芽组织及疣。

Associated Conditions

No associated conditions information available.

FDA Approved Products

Avoca Flexible Caustic Applicator
Manufacturer:Bray Group Limited
Route:TOPICAL
Strength:30 mg in 40 mg
Approved: 2018/07/18
NDC:65875-101
GRAFCO APPLICATOR 15 CM
Manufacturer:GF Health Products, Inc.
Route:TOPICAL
Strength:38.21 mg in 1 1
Approved: 2021/01/19
NDC:12165-100
Repara Silver Nitrate Applicators
Manufacturer:PSS World Medical, Inc.
Route:TOPICAL
Strength:75 mg in 1 1
Approved: 2012/10/26
NDC:68345-100
GRAFCO APPLICATOR 30 CM
Manufacturer:GF Health Products, Inc.
Route:TOPICAL
Strength:52.451 mg in 1 1
Approved: 2020/01/02
NDC:12165-200
GRAFCO APPLICATOR 45 CM
Manufacturer:GF Health Products, Inc.
Route:TOPICAL
Strength:73.4314 mg in 1 1
Approved: 2019/12/04
NDC:12165-300

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath